Vir Biotechnology, Inc. · BX:VIR

Vir Biotechnology, Inc. insider trades

Vir Biotechnology, Inc.'s insiders made 0 buys and 7 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
de Verneuil Vanina
Officer: EVP, General Counsel, Corp Sec
Sale2,407USD 11.10US$26,718Nov 3, 2026
de Verneuil Vanina
Officer: EVP, General Counsel, Corp Sec
Sale1,343USD 11.33US$15,222Nov 2, 2026
Sabatini Brent
Officer: SVP, Chief Accounting Officer
Sale379USD 9.45US$3,582Jun 1, 2026
Napolitano Janet
Director
Sale3,200USD 9.45US$30,240Jun 1, 2026
Sato Vicki L
Director
Sale22,000USD 10.05US$221KMay 1, 2026
De Backer Marianne
Director, Officer: President and CEO
Sale72,559USD 9.16US$665KApr 6, 2026
Sato Vicki L
Director
Sale22,000USD 9.07US$200KApr 1, 2026

Vir Biotechnology, Inc. shareholders